4Moving Biotech, a spin-off of 4P-Pharma developing the first potential disease-modifying drug (DMOAD) for knee osteoarthritis, announced that it has been awarded €7.6 million in funding under the ...

Manager chosen for Providence biotech incubator Four board members to exit troubled RI biotech Four board members to exit troubled RI biotech RI biotech wins FDA nod for eye insert RI biotech wins ...

ERBC, a leading preclinical contract research organization (CRO), and Menarini Biotech, a Menarini Group company, offering services as a custom development and manufacturing organization (CDMO), ...

Early-stage biotechnology innovators from around the ... deploying a total of $4 million and providing incubator space and mentorship, in partnership with Lilly and OVI: Aperture Therapeutics ...